Skip to main content

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

Teva-Acyclovir

Covered
  • Active ingredient(s):
  • Manufactured by:
    Teva Canada Ltée (Teva Can)
  • Strength and dosage form:
    • Tablet 200 mg DIN : 2285959
    • Tablet 400 mg DIN : 2285967
    • Tablet 800 mg DIN : 2285975

Acyclovir Sodique

Covered
  • Active ingredient(s):
  • Manufactured by:
    Fresenius Kabi Canada Ltd. (Fresenius)
  • Strength and dosage form:
    • Intravenous Perfusion Solution 50 mg/mL (10 mL) DIN : 2236926
    • Intravenous Perfusion Solution 50 mg/mL (20 mL) DIN : 99106493

Acyclovir sodique injectable

Covered
  • Active ingredient(s):
  • Manufactured by:
    Sterimax Inc. (Sterimax)
  • Strength and dosage form:
    • Intravenous Perfusion Solution 50 mg/mL (10 mL) DIN : 2456524
    • Intravenous Perfusion Solution 50 mg/mL (20 mL) DIN : 99106293

Acyclovir Sodium Injection

Covered
  • Active ingredient(s):
  • Manufactured by:
    Auro Pharma Inc. (AuroPharma)
  • Strength and dosage form:
    • Intravenous Perfusion Solution 50 mg/mL (10 mL) DIN : 2494558
    • Intravenous Perfusion Solution 50 mg/mL (20 mL) DIN : 99113861

Hyrimoz (syringe)

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Sandoz Canada Inc (Sandoz)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,2 mL) DIN : 2542315
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2542323
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 2542358
    • Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 2505258
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 2492164

Hadlima PushTouch (pen)

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Organon Canada Inc. (Organon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2533480
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 2473100

Hadlima (syringe)

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Organon Canada Inc. (Organon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2533472
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 2473097

Hyrimoz (pen)

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Sandoz Canada Inc (Sandoz)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2542331
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 2542366
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 2492156

Simlandi (syringe)

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2523949
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 2523965

Simlandi (pen)

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2523957

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.